Reference Listed Drug (RLD) and Reference Standard (RS)
Reference Listed Drugs (RLD) refer to the reference products used for evaluating the quality and therapeutic equivalence of generic drugs. These are typically the originator products being, or internationally recognized equivalents. The journey of generic drug development begins with the RLD.
HSP Medical boasts a professional team with years of experience in the pharmaceutical R&D and sales sectors. We are committed to assisting Chinese pharmaceutical companies in successfully taking the crucial first step in generic drug development. We provide accurate and unambiguous RLD product information (such as manufacturer or Marketing Authorization Holder details), offer expert solutions to challenges encountered during the RLD sourcing process, and clarify relevant regulatory procedures. This helps mitigate potential regulatory issues and risks during later-stage CDE inspections or the drug approval process.
While ensuring high-quality service, HSP Medical offers competitive pricing, short lead times, and comprehensive after-sales support. We strive to meet and exceed the expectations of our Chinese pharmaceutical clients, aiming to establish long-term and stable partnerships.